• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THERAKOS, INC. CELLEX PHOTOPHERESIS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THERAKOS, INC. CELLEX PHOTOPHERESIS SYSTEM Back to Search Results
Model Number NOT APPLICABLE
Device Problem Device Displays Incorrect Message (2591)
Patient Problem Thrombus (2101)
Event Date 02/13/2019
Event Type  malfunction  
Manufacturer Narrative
The system was used for treatment.This case is reportable as a mdr due to the reportable malfunction clot observed in the return line.Since this reportable malfunction is only associated with the kit, this mdr will only be against the kit.A batch record review for kit lot g374 was conducted.There were no non-conformances associated with this lot.This lot met all release requirements.A review of kit lot g374 for the reported issue shows no trends.Trends were reviewed for complaint categories, clot observed and alarm #17: return pressure.No trends were detected for each complaint category.Photographs were provided by the customer for evaluation.The smartcard was not returned; therefore, the alarm #17: return pressure could not be verified.A review of the photographs confirm clotting in the return bag as reported by the customer.The customer reported seeing a clot in the return line, however the photographs provided do not show the return line and therefore clotting in that location cannot be verified.The customer reported using 10,000 units of heparin in 500ml of normal saline, the default anticoagulant (a/c) ratio for the cellex photopheresis system.Section 2-9 of the cellex operators manual (1460415 rev 5.0) on anticoagulant states "caution: individual patients may require a heparin dosage that varies from the recommended dose to prevent post-treatment bleeding or clotting during a treatment.The physician should review the patient's medical condition, medications and platelet count at the time of treatment and use clinical judgement to establish the optimal heparin dosage for each patient." the root cause for the clot observed could not be determined based on the available information.No further action is required at this time.This investigation is now complete.(b)(4).
 
Event Description
The customer called to report clots observed in the return line and return bag during the treatment procedure.The customer stated they received an alarm #17: return pressure alarm and flushed the patient's access in an attempt to resolve the alarm.The customer received another return pressure alarm and disconnected the return line to run a saline bolus through the return line.The customer stated when performing the saline bolus they noticed a clot in the return line.The customer stated they inspected the kit and found further clotting in the return bag.The customer aborted the treatment and did not return blood to the patient.The customer reported the patient was stable.The customer returned photographs for investigation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CELLEX PHOTOPHERESIS SYSTEM
Type of Device
CELLEX PHOTOPHERESIS SYSTEM
Manufacturer (Section D)
THERAKOS, INC.
bedminster NJ 07921
Manufacturer (Section G)
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
college business & tech park
cruiserath road
blanchardstown, dublin D15 T X2V
EI   D15 TX2V
Manufacturer Contact
megan vernak
1425 us route 206
bedminster, NJ 07921
MDR Report Key8370708
MDR Text Key139100216
Report Number2523595-2019-00037
Device Sequence Number1
Product Code LNR
UDI-Device Identifier20705030200003
UDI-Public(01)20705030200003(10)G374(17)201001
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P860003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Nurse
Type of Report Initial
Report Date 02/26/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/01/2020
Device Model NumberNOT APPLICABLE
Device Catalogue NumberCLXUSA
Device Lot NumberG374
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/13/2019
Initial Date FDA Received02/26/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/16/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age53 YR
-
-